Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which...


Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which includes the full over-allotment exercise, at $2.70 per share, an actual 3% premium to today's closing price of $2.62. Demand for the deal was high, and the sale will generate around $12.5M in gross proceeds before the underwriting discount and other offering costs are deducted. Shares +1.9% AH.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs